Alle verbonden artikelen

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.

Auteurs : Awada A, Colomer R, Inoue K, Bondarenko I, Badwe RA, Demetriou G, Lee SC, Mehta AO, Kim SB, Bachelot T, Goswami C, Deo S, Bose R, Wong A, Xu F, Yao B, Bryce R, Carey LA
Jaar : 2016
Journal : JAMA Oncol
Volume : 2(12)
Pagina's : 1557-64

Moderne indications for endoscopic endonasal surgery

Auteurs : Lipski SM, Digonnet A, Dolhen P
Jaar : 2016
Journal : EMJ Oncology
Volume : -
Pagina's : -

Frequent incidence of BARD1 truncating mutations in germline DNA from triple negative breast cancer patients.

Auteurs : De Brakeleer S, De Grève J, Desmedt C, Joris S, Sotiriou C, Piccart-Gebhart M, Pauwels I, Teugels E
Jaar : 2016
Journal : Clin. Genet.
Volume : 89(3)
Pagina's : 336-40.

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Auteurs : Phillips RS, Sung L, Amman RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA
Jaar : 2016
Journal : Br J Cancer
Volume : 114
Pagina's : 623-630

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience.

Auteurs : Metzger-Filho O, de Azambuja E, Procter M, Krieguer M, Smith I, Baselga J, Cameron D, Untch M, Jackisch C, Bell R, Gianni L, Goldhirsch A, Piccart-Gebhart M, Gelber Rd
Jaar : 2016
Journal : Breast Cancer Res Treat
Volume : 155
Pagina's : 127-32

Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French So

Auteurs : Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M
Jaar : 2016
Journal : Ann Intensive Care
Volume : 6
Pagina's : 90

Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes.

Auteurs : Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V, Sjövall A, Brge Johannesen T, Moreau M, Liberale G, Gonçalves AF, Bento MJ, van de Velde T, Kempfer LR, Becker N, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H
Jaar : 2016
Journal : Medicine (Baltimore)
Volume : 95(22)
Pagina's : e3812

Phosphoethanolamine and the danger of unproven drugs.

Auteurs : Pondé N, de Azambuja E, Ades F
Jaar : 2016
Journal : Ecancermedicalscience
Volume : 10
Pagina's : 681

Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation.

Auteurs : Cairns L, Aspeslagh S, Anichini A, Kyte JA, Blank C, Ascierto P, Rekers N, Straten PT, Awada A
Jaar : 2016
Journal : Ecancermedicalscience
Volume : 10
Pagina's : 691

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Auteurs : Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, Von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J, + collaborators (among others :, Nogaret JM
Jaar : 2016
Journal : Lancet
Volume : 387
Pagina's : 866-73

Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.

Auteurs : Li R, Swaelens C, Vandermijnsbrugge F, Cantinieaux B
Jaar : 2016
Journal : Eur. J. Haematol.
Volume : 96(6)
Pagina's : 578-85

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.

Auteurs : Harbeck N, Huang CS, Hurvitz S, Yeh DC, Shao Z, Im SA, Jung KH, Shen K, Ro J, Jassem J, Zhang Q, Im YH, Wojtukiewicz M, Sun Q, Chen SC, Goeldner RG, Uttenreuther-Fischer M, Xu B, Piccart-Gebhart M
Jaar : 2016
Journal : Lancet Oncol
Volume : 17(3)
Pagina's : 357-66

MicroRNAs regulate KDM5 histone demethylases in breast cancer cells.

Auteurs : Denis H, Van Grembergen O, Delatte B, Dedeurwaerder S, Putmans P, Calonne E, Rothé F, Sotiriou C, Fuks F, Deplus R
Jaar : 2016
Journal : Mol Biosyst
Volume : 12(2)
Pagina's : 404-13

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Auteurs : Cardoso F, Vant Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, Delorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart-Gebhart M
Jaar : 2016
Journal : N Engl J Med
Volume : 375(8)
Pagina's : 717-29

Corrigendum to Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]."

Auteurs : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2016
Journal : J Geriatr Oncol
Volume : 7
Pagina's : 142-143

Screening leading to diagnosis of C cell disease. (in Tyroid cancer : a clinical casebook.) (D. Cooper & C. Durante Eds. Springer)

Auteurs : Costante G
Jaar : 2016
Journal : Book
Volume : -
Pagina's : 377-85

(1, 3)-ß-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.

Auteurs : Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Bretagne S, Lebert C, Meert AP, Benoit D, Pene F
Jaar : 2016
Journal : Oncotarget
Volume : 7(16)
Pagina's : 21484-95

Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors.

Auteurs : Aspeslagh S, Awada A, S Matos-Pita A, Aftimos P, Bahleda R, Varga A, Soria JC
Jaar : 2016
Journal : Anticancer Drugs
Volume : 27
Pagina's : 1021-7

Phase 2 Study of Trabectedin in Patients With Hormone Receptor-Positive, HER-2-Negative, Advanced Breast Carcinoma According to Expression of Xeroderma Pigmentosum G Gene.

Auteurs : Awada A, Cortés J, Martín M, Aftimos P, Oliveira M, López-Tarruella S, Espie M, Lardelli P, Extremera S, Fernández-García EM, Delaloge S
Jaar : 2016
Journal : Clin Breast Cancer
Volume : 16(5)
Pagina's : 364-71

I-SPY 2: optimising cancer drug development in the 21st century.

Auteurs : Bartsch R, de Azambuja E
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000113